Dilated cardiomyopathy (DCM) is a disease of the heart muscle (myocardium). It belongs to a group of diseases of the myocardium which are all defined by structural and functional abnormalities of the ventricles.
DCM usually begins in the left ventricle. Over time the ventricle stretches and its walls grow thinner to the point where the heart cannot pump the blood as effectively anymore. For some people, dilated cardiomyopathy can be totally asymptomatic, but due to its diversity it can also present as a life-threatening condition. DCM is a common cause of heart failure, irregular heart rhythms (arrhythmias), blood clots and sudden death.(2)
What makes the DCM stand out is the extensive list of causes behind it. The common causes include infections and gene mutations, but there are also DCMs associated with alcohol, long term tachycardia or many other underlying conditions such as autoimmune diseases, coronary artery disease, heart attack, high blood pressure, diabetes, hemochromatosis, end-stage kidney disease, sarcoidosis, neuromuscular diseases, etc. (4,5)
Take a look at the most common causes in the following table:
The annual incidence of DCM is estimated at five to eight cases per 100,000 population, with a prevalence of 36 cases per 100,000 population (to give you a better idea, the estimated prevalence in the US is around 1:2500). However, these figures may underestimate the incidence of the disease, as many patients remain undiagnosed due to incomplete expression of the disease. (1)
A person is more prone to develop dilated cardiomyopathy in presence of several risk factors:
To date, genetic studies of familial dilated cardiomyopathy (FDC) have implicated more than 60 genes in the pathogenesis of DCM. (9) Most FDCs are inherited in an autosomal dominant fashion, but autosomal recessive, X-linked and mitochondrial inheritance have also been reported. Although many genes have been identified to date, it is estimated that they represent only about half of the genetic causes of FDC. (6) Of the mutations described so far, the most common are mutations in genes encoding structural proteins of the cell (e.g. titin, dystrophin, emerin, sarcomere proteins, cytoskeleton, etc.). (7)
According to the existing data, dilated cardiomyopathy is not age-dependent, however it is most often manifested between 30 and 40 years of age. (7)
As the disease progresses over time and the heart’s ability to pump blood declines, several specific symptoms may appear: (7)
If the right ventricle is also affected patients often develop signs of congestion in the venous system:
In addition to the already listed symptoms, others such as palpitations, chest pain, presyncope and syncope are also sometimes described.
If the condition is left untreated, it may lead to other health problems. These complications include:
The diagnosis of dilated cardiomyopathy and the search for its etiology is difficult, but at the same time essential as a large part of the wide range of underlying causes is partly or completely reversible. (8) Number of tests and specific methods may be used in the process:
If the etiology of DCM is known, treatment is focused on it. Under normal circumstances, treatment can help relieve or eliminate symptoms, improve blood circulation and prevent further damage to the heart. (2) On occasion, the heart reverse remodelling can also be achieved. (9)
In general, the following methods are most commonly (but not always) used: (2)
Studies suggest that dilated cardiomyopathy is caused by genetic mutations in up to one third of patients. Although preventive measures may not prevent the disease in these cases altogether, healthy lifestyle habits can help prevent or significantly reduce the complications. (2)
Patients with DCM or in high risk of developing it are advised to: (2)
The prognosis of patients has improved significantly in the last decades with the development of approaches in the treatment of heart failure. Nevertheless, previous studies have shown that after the age of 60, DCM is the second most common cause of heart transplantation after ischaemic heart disease, accounting for 39% of all heart transplants. (9)
It appears that the prognosis of patients depends on many factors, such as:
Despite major progress in treatment, heart failure remains the leading cause of death in patients with dilated cardiomyopathy. (9)
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop